Barakah Profits › United States stocks A–Z

Is Biogen Inc. (BIIB) halal?

Yes. Biogen Inc. (BIIB) passes our halal screen, as of 18 November 2026. It passes every check.

NASDAQ · Healthcare · Screened 18 November 2026. Its verdict has not changed since our public ledger began on 24 September 2026.

The four checks

Business activityPassFrom the 10-K (2025): Biogen's revenue is entirely derived from the sale and collaboration on pharmaceutical products for various serious diseases, with Multiple Sclerosis products being the largest segment at 40.81%.
Interest-bearing debtPassTotal debt is 22.6% of market cap (limit 30%).
Cash & interest-bearing securitiesPassCash & securities are 3.5% of market cap (limit 30%).
Non-permissible income (< 5%)PassInterest income is 1.3% of revenue (limit 5%). The annual report shows no other non-permissible revenue.

Verdict history

No changes recorded since 24 September 2026.

See every change across all stocks on the public verdict ledger.

Frequently asked questions

Is Biogen Inc. stock halal?

Yes. Biogen Inc. (BIIB) passes our halal screen, as of 18 November 2026. It passes every check.

Why can Biogen Inc.'s halal status change?

Two of the tests compare debt and cash with the company's market value. When the share price moves, those ratios move, so a stock can cross the 30% line without the business changing at all. Its verdict has not changed since our public ledger began on 24 September 2026.

How does Barakah Profits screen stocks?

We use an AAOIFI-style screen: the business itself must be permissible, interest-bearing debt and interest-bearing cash must each be under 30% of market value, and non-permissible income must be under 5% of revenue. It is an automated estimate, not a fatwa.

Check any stock

Free halal check for US, Australian, Malaysian and Singapore stocks.

Check a stock

AAOIFI-style screen by Barakah Profits. Automated estimate, not a fatwa. Always confirm with a qualified scholar before investing. Financial data provided by Twelve Data. This is general information, not financial advice.